<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Suske, G.</title>
    <link>http://repub.eur.nl/res/aut/6358/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5 (Article)</title>
      <link>http://repub.eur.nl/res/pub/33854/</link>
      <pubDate>2011-07-01T00:00:00Z</pubDate>
      <description>Objective: The transcription factor PAX5 is essential for the activation of B-cell-specific genes and for the silencing of myeloid-specific genes. We previously determined the molecular mechanism by which PAX5 silences the myeloid-specific colony-stimulating-factor-receptor (Csf1R) gene and showed that PAX5 directly binds to the Csf1r promoter as well as to an intronic enhancer that generates an antisense transcript in B cells. Here we examine the role of PAX5 in the regulation of sense and antisense transcription in B cells. Materials and Methods: We performed PAX5-specific chromatin immunoprecipitation analyses across the Csfr1 locus. We investigated the role of PAX5 in regulating Csf1r sense and antisense promoter activity by transient transfections and by employing a Pax5-/-pro-B-cell line expressing an inducible PAX5 protein. PAX5 interacting factors were identified by pull-down experiments. The role of the transcription factor Sp3 in driving antisense promoter expression was examined in B cells from Sp3 knockout mice. Results: PAX5 differentially regulates the Csf1r promoter and the promoter of the antisense transcript. PAX5 interferes with PU.1 transactivation at the sense promoter by binding to a PAX5 consensus sequence. At the antisense promoter, PAX5 does not specifically recognize DNA, but interacts with Sp3 to upregulate antisense promoter activity. Antisense promoter activation by PAX5 is dependent on the presence of its partial homeo-domain. Conclusions: We demonstrate that PAX5 regulates Csf1r in B cells by reducing the frequency of binding of the basal transcription machinery to the promoter and by activating antisense RNA expression. </description>
    </item> <item>
      <title>Epigenetic silencing of spermatocyte-specific and neuronal genes by SUMO modification of the transcription factor sp3 (Article)</title>
      <link>http://repub.eur.nl/res/pub/28550/</link>
      <pubDate>2010-11-01T00:00:00Z</pubDate>
      <description>SUMO modification of transcription factors is linked to repression of transcription. The physiological significance of SUMO attachment to a particular transcriptional regulator, however, is largely unknown. We have employed the ubiquitously expressed murine transcription factor Sp3 to analyze the role of SUMOylation in vivo. We generated mice and mouse embryonic fibroblasts (MEFs) carrying a subtle point mutation in the SUMO attachment sequence of Sp3 (IKEE553D mutation). The E553D mutation impedes SUMOylation of Sp3 at K551in vivo, without affecting Sp3 protein levels. Expression profiling revealed that spermatocyte-specific genes, such as Dmc1 and Dnahc8, and neuronal genes, including Paqr6, Rims3, and Robo3, are de-repressed in non-testicular and extra-neuronal mouse tissues and in mouse embryonic fibroblasts expressing the SUMOylation-deficient Sp3E553D mutant protein. Chromatin immunoprecipitation experiments show that transcriptional de-repression of these genes is accompanied by the loss of repressive heterochromatic marks such as H3K9 and H4K20 tri-methylation and impaired recruitment of repressive chromatin-modifying enzymes. Finally, analysis of the DNA methylation state of the Dmc1, Paqr6, and Rims3 promoters by bisulfite sequencing revealed that these genes are highly methylated in Sp3wt MEFs but are unmethylated in Sp3E553D MEFs linking SUMOylation of Sp3 to tissue-specific CpG methylation. Our results establish SUMO conjugation to Sp3 as a molecular beacon for the assembly of repression machineries to maintain tissue-specific transcriptional gene silencing. </description>
    </item> <item>
      <title>Sp1/Sp3 compound heterozygous mice are not viable: Impaired erythropoiesis and severe placental defects (Article)</title>
      <link>http://repub.eur.nl/res/pub/36604/</link>
      <pubDate>2007-08-01T00:00:00Z</pubDate>
      <description>The ubiquitously expressed zinc finger transcription factors Sp1 and Sp3 play critical roles in embryonic development. Sp1 knockout mice die around embryonic day 10.5. Mice lacking Sp3 are postnatal lethal. Mice heterozygous for either Sp1 or Sp3 are apparently normal, although slightly smaller. Here, we show that compound heterozygosity of Sp1 and Sp3 results in embryonic lethality accompanied by a spectrum of developmental abnormalities, including growth retardation, morphological alterations of the lung, impaired ossification, anemia, and placental defects. Anemia in Sp1/Sp3 compound heterozygous mutant embryos is associated with impaired maturation of erythrocytes. Analyses of the placenta revealed a markedly reduced spongiotrophoblast layer and a severe disorganization of the labyrinth layer in Sp1/Sp3 compound heterozygous as well as in Sp3-deficient mutant embryos. Our findings demonstrate that a threshold of Sp1 and Sp3 activity is required for normal embryonic development, suggesting that Sp1 and Sp3 act cooperatively to regulate downstream targets. </description>
    </item> <item>
      <title>Impaired hematopoiesis in mice lacking the transcription factor Sp3 (Article)</title>
      <link>http://repub.eur.nl/res/pub/8232/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>As the zinc-finger transcription factor specificity protein 3 (Sp3) has
      been implicated in the regulation of many hematopoietic-specific genes, we
      analyzed the role of Sp3 in hematopoiesis. At embryonic day 18.5 (E18.5),
      Sp3-/- mice exhibit a partial arrest of T-cell development in the thymus
      and B-cell numbers are reduced in liver and spleen. However, pre-B-cell
      proliferation and differentiation into immunoglobulin M-positive (IgM+) B
      cells in vitro are not affected. At E14.5 and E16.5, Sp3-/- mice exhibit a
      significant delay in the appearance of definitive erythrocytes in the
      blood, paralleled by a defect in the progression of differentiation of
      definitive erythroid cells in vitro. Perinatal death of the null mutants
      precludes the analysis of adult hematopoiesis in Sp3-/- mice. We therefore
      investigated the ability of E12.5 Sp3-/- liver cells to contribute to the
      hematopoietic compartment in an in vivo transplantation assay. Sp3-/-
      cells were able to repopulate the B- and T-lymphoid compartment, albeit
      with reduced efficiency. In contrast, Sp3-/- cells showed no significant
      engraftment in the erythroid and myeloid lineages. Thus, the absence of
      Sp3 results in cell-autonomous hematopoietic defects, affecting in
      particular the erythroid and myeloid cell lineages.</description>
    </item> <item>
      <title>Transcription factor Sp3 is essential for post-natal survival and late tooth development. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2592/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Sp3 is a ubiquitously expressed transcription factor closely related to Sp1 (specificity protein 1). We have disrupted the mouse Sp3 gene by homologous recombination. Sp3-deficient embryos are growth retarded and invariably die at birth of respiratory failure. The cause for the observed breathing defect remains obscure since only minor morphological alterations were observed in the lung, and surfactant protein expression is indistinguishable from that in wild-type mice. Histological examinations of individual organs in Sp3-/- mice show a pronounced defect in late tooth formation. In Sp3 null mice, the dentin/enamel layer of the developing teeth is impaired due to the lack of ameloblast-specific gene products. Comparison of the Sp1 and Sp3 knockout phenotype shows that Sp1 and Sp3 have distinct functions in vivo, but also suggests a degree of functional redundancy.</description>
    </item> <item>
      <title>A tale of three fingers: the family of mammalian Sp/XKLF transcription factors (Article)</title>
      <link>http://repub.eur.nl/res/pub/9152/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>One of the most common regulatory elements is the GC box and the related
          GT/CACC box, which are widely distributed in promoters, enhancers and
          locus control regions of housekeeping as well as tissue-specific genes.
          For long it was generally thought that Sp1 is the major factor acting
          through these motifs. Recent discoveries have shown that Sp1 is only one
          of many transcription factors binding and acting through these elements.
          Sp1 simply represents the first identified and cloned protein of a family
          of transcription factors characterised by a highly conserved DNA-binding
          domain consisting of three zinc fingers. Currently this new family of
          transcription factors has at least 16 different mammalian members. Here,
          we will summarise and discuss recent advances that have been directed
          towards understanding the biological role of these proteins.</description>
    </item>
  </channel>
</rss>